참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | psi-Pelletierine | HCID 11096 | — |
| 반응물 | Npc164516 | HCID 79038 | — |
| 반응물 | Diethyl(5-isoxazolylmethyl)phosphonate | HCID 11378989 | — |
| 반응물 | Diisobutylaluminumhydride | HCID 21225700 | — |
| 생성물 | (E)-5-(2-(8-azabicyclo[3.2.1]oct-6-yl)ethenyl)isoxazole | HCID 9855792 | — |
| 생성물 | (Z)-5-(2-(8-azabicyclo[3.2.1]oct-6-yl)ethenyl)isoxazole | HCID 69588569 | — |
반응 단계
The synthesis of arylethenyl-substituted 8-azabicyclo[3.2.1]octanes and arylethynyl-substituted 8-azabicyclo[3.2.1]octanes are accomplished in a manner similar to that described for arylethenyl-substituted 7-azabicyclo[2.2.1]heptanes and arylethynyl-substituted 7-azabicyclo[2.2.1]heptanes. Treatment of pseudopelletierine (N-methyl-9-azabicyclo[3.3.1]nonan-3-one) as described earlier for tropinone (Daly et al. Eur. J. Pharmacol. 321:189-194 (1997)) will generate ethyl 8-aza-6-(ethoxycarbonyl)bicyclo[3.2.1]octane-8-carboxylate. Pseudopelletierine is made according to Howell et al., Org. Syn. Coll. Vol IV: 816-819 (1963). Reduction of ethyl 8-aza-6-(ethoxycarbonyl)bicyclo[3.2.1]octane-8-carboxylate with diisobutylaluminum hydride and subsequent reaction of the 6-formyl derivative with diethyl (5-isoxazolylmethyl)phosphonate and n-butylithium will provide mixture of ethyl (E)- and (Z)-5-(2-(8-azabicyclo[3.2.1]oct-6-yl)ethenyl)isoxazole-8-carboxylate. Separation of the isomers followed by deprotection will provide (E)-5-(2-(8-azabicyclo[3.2.1]oct-6-yl)ethenyl)isoxazole and (Z)-5-(2-(8-azabicyclo[3.2.1]oct-6-yl)ethenyl)isoxazole. The other methods described previously for the preparation of five-membered heterocycle analogues of ethenyl-substituted 7-azabicyclo[2.2.1]heptanes may be applied similarly.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06624167B1 |
|---|
| 출처 데이터셋 | uspto-grants-2003_09 |
|---|
| ORD ID | ord-0129d242b1d74a1185d4b8d147c7113c |
|---|
| 출처 메모 | uspto-grants-2003_09 |
|---|